These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12200189)

  • 21. Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Deleu D
    Acta Neurol Belg; 1998 Dec; 98(4):319-21. PubMed ID: 9922818
    [No Abstract]   [Full Text] [Related]  

  • 22. Sal synthase induced cytotoxicity of PC12 cells through production of the dopamine metabolites salsolinol and N-methyl-salsolinol.
    Xiong Q; Zheng X; Wang J; Chen Z; Deng Y; Zhong R; Wang J; Chen X
    J Integr Neurosci; 2022 Mar; 21(2):71. PubMed ID: 35364659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells.
    Wang R; Qing H; Liu XQ; Zheng XL; Deng YL
    Neurosci Bull; 2008 Jun; 24(3):125-32. PubMed ID: 18500384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W; Yi H; Takahashi T; Shimazu S; Ohde H; Yoneda F; Iwasa K; Naoi M
    Life Sci; 2004 May; 75(1):107-17. PubMed ID: 15102525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells.
    Takahashi T; Maruyama W; Deng Y; Dostert P; Nakahara D; Niwa T; Ohta S; Naoi M
    J Neural Transm (Vienna); 1997; 104(1):59-66. PubMed ID: 9085193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein.
    Wanpen S; Govitrapong P; Shavali S; Sangchot P; Ebadi M
    Brain Res; 2004 Apr; 1005(1-2):67-76. PubMed ID: 15044066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.
    Yi H; Akao Y; Maruyama W; Chen K; Shih J; Naoi M
    J Neurochem; 2006 Jan; 96(2):541-9. PubMed ID: 16336631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
    Naoi M; Maruyama W; Dostert P; Hashizume Y; Nakahara D; Takahashi T; Ota M
    Brain Res; 1996 Feb; 709(2):285-95. PubMed ID: 8833765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. R- and S-salsolinol are not increased in cerebrospinal fluid of Parkinsonian patients.
    Müller T; Sällström Baum S; Häussermann P; Przuntek H; Rommelspacher H; Kuhn W
    J Neurol Sci; 1999 Apr; 164(2):158-62. PubMed ID: 10402028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondria determine the survival and death in apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, and neuroprotection by propargylamines.
    Naoi M; Maruyama W; Akao Y; Yi H
    J Neural Transm (Vienna); 2002 May; 109(5-6):607-21. PubMed ID: 12111453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
    Naoi M; Maruyama W; Nagy GM
    Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol.
    Maruyama W; Akao Y; Youdim MB; Davis BA; Naoi M
    J Neurochem; 2001 Aug; 78(4):727-35. PubMed ID: 11520893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
    Maruyama W; Nakahara D; Ota M; Takahashi T; Takahashi A; Nagatsu T; Naoi M
    J Neurochem; 1992 Aug; 59(2):395-400. PubMed ID: 1629715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2.
    Yi H; Maruyama W; Akao Y; Takahashi T; Iwasa K; Youdim MB; Naoi M
    J Neural Transm (Vienna); 2006 Jan; 113(1):21-32. PubMed ID: 15843867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future of neuroprotection in Parkinson's disease.
    Naoi M; Maruyama W
    Parkinsonism Relat Disord; 2001 Oct; 8(2):139-45. PubMed ID: 11489679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
    Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
    Brain Res Bull; 2001 Sep; 56(1):55-60. PubMed ID: 11604249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of dopamine and dopamine-derived (R)-/(S)-salsolinol and norsalsolinol in various human brain areas using solid-phase extraction and gas chromatography/mass spectrometry.
    Musshoff F; Schmidt P; Dettmeyer R; Priemer F; Jachau K; Madea B
    Forensic Sci Int; 2000 Sep; 113(1-3):359-66. PubMed ID: 10978649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (R)salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes.
    Naoi M; Maruyama W; Nakao N; Ibi T; Sahashi K; Benedetti MS
    Ann Neurol; 1998 Feb; 43(2):212-6. PubMed ID: 9485062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.
    Zheng X; Chen X; Guo M; Ali S; Huang Y; Sun F; Liu K; Chen Z; Deng Y; Zhong R
    Neurosci Lett; 2018 Apr; 673():39-43. PubMed ID: 29454627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of R- and S-salsolinol are not increased in "de-novo" Parkinsonian patients.
    Müller T; Sällström Baum S; Häussermann P; Woitalla D; Rommelspacher H; Przuntek H; Kuhn W
    J Neural Transm (Vienna); 1998; 105(2-3):239-46. PubMed ID: 9660101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.